These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2194428)

  • 21. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy.
    Sindern E; Stark E; Haas J; Steck AJ
    Acta Neurol Scand; 1991 Jun; 83(6):399-402. PubMed ID: 1887763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies.
    O'Hanlon GM; Paterson GJ; Veitch J; Wilson G; Willison HJ
    Acta Neuropathol; 1998 Jun; 95(6):605-16. PubMed ID: 9650753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.
    Nobile-Orazio E; Giannotta C; Musset L; Messina P; Léger JM
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):754-8. PubMed ID: 23907602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects.
    McGinnis S; Kohriyama T; Yu RK; Pesce MA; Latov N
    J Neuroimmunol; 1988 Jan; 17(2):119-26. PubMed ID: 2447123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.
    Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM
    Adv Exp Med Biol; 1984; 174():455-61. PubMed ID: 6741739
    [No Abstract]   [Full Text] [Related]  

  • 27. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?
    Bartolomei F; Boucraut J; Barrié M; Kok J; Dravet C; Viallat D; Bernard D; Gastaut JL
    Epilepsia; 1996 Oct; 37(10):922-6. PubMed ID: 8822688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.
    Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM
    J Immunol; 1984 Apr; 132(4):1793-7. PubMed ID: 6699401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of major gangliosides in the PNS: implications for immune neuropathies.
    Gong Y; Tagawa Y; Lunn MP; Laroy W; Heffer-Lauc M; Li CY; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2002 Nov; 125(Pt 11):2491-506. PubMed ID: 12390975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
    Willison HJ; Paterson G; Kennedy PG; Veitch J
    Ann Neurol; 1994 Apr; 35(4):471-8. PubMed ID: 8154875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiography of ganglioside antigens separated by high-performance thin-layer chromatography with their antibodies.
    Kasai N; Naiki M; Yu RK
    J Biochem; 1984 Jul; 96(1):261-4. PubMed ID: 6490603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Demonstration by ELISA and relation to serum in vivo demyelinating activity.
    Schwerer B; Kitz K; Lassmann H; Bernheimer H
    J Neuroimmunol; 1984 Dec; 7(2-3):107-19. PubMed ID: 6511889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis.
    Lopez PH; Lardone RD; Irazoqui FJ; Maccioni M; Nores GA
    Neurochem Res; 2002 Aug; 27(7-8):687-95. PubMed ID: 12374203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barré syndrome associated with IgG anti-GM1b antibody subsequent to Mycoplasma pneumoniae infection.
    Kitazawa K; Tagawa Y; Honda A; Yuki N
    J Neurol Sci; 1998; 156(1):99-101. PubMed ID: 9559995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses, and disease.
    Gatterbauer B; Neisser A; Bernheimer H; Schwerer B
    Ann N Y Acad Sci; 1998 Jun; 845():353-62. PubMed ID: 9668368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.